Interpace Diagnostics Group Inc. buy melinda
Start price
23.10.17
/
50%
€13.60
Target price
26.12.17
€17.00
Performance (%)
-30.88%
End price
26.12.17
€9.40
Summary
This prediction ended on 26.12.17 with a price of €9.40. Massive losses of -30.88% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Interpace Diagnostics Group Inc. | - | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
Comments by melinda for this prediction
In the thread Interpace Diagnostics Group Inc. diskutieren
Diagnose Interpace vorhanden wichtige Daten in der Gastroenterologie - Weltkongress des American College of Gastroenterology (ACG) 2017
Präsentationen PancraGEN® BarreGEN® und vom Kollegium angenommen
(Vom Mitglied beendet)
Stopped prediction by melinda for Interpace Diagnostics Group Inc.
Interpace Diagnostics Group Inc.
Start price
Target price
Perf. (%)
€12.27
23.10.17
23.10.17
€15.33
26.12.17
26.12.17
-30.88%
26.12.17
26.12.17
Interpace Diagnostics Group Inc.
Start price
Target price
Perf. (%)
€8.03
29.06.17
29.06.17
€15.33
24.08.17
24.08.17
40.45%
24.08.17
24.08.17
Interpace Diagnostics Group Inc.
Start price
Target price
Perf. (%)
€20.32
07.04.17
07.04.17
€30.67
18.04.17
18.04.17
68.51%
18.04.17
18.04.17